Derek J. Hart
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation.
Journal: Molecular oncology
Published: June 05, 2019
CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential.
Journal: Frontiers in immunology
Published: March 14, 2019
Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.
Journal: PloS one
Published: February 07, 2019
Distinguishing human peripheral blood CD16+ myeloid cells based on phenotypic characteristics.
Journal: Journal of leukocyte biology
Published: September 19, 2018
Dendritic cells as cancer therapeutics.
Journal: Seminars in cell & developmental biology
Published: September 12, 2017
The cell surface phenotype of human dendritic cells.
Journal: Seminars in cell & developmental biology
Published: September 11, 2017
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma.
Journal: Haematologica
Published: August 22, 2017
Bone Marrow Graft-Versus-Host Disease in Major Histocompatibility Complex-Matched Murine Reduced-Intensity Allogeneic Hemopoietic Cell Transplantation.
Journal: Transplantation
Published: March 21, 2017
The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 02, 2016
Nomenclature of CD molecules from the Tenth Human Leucocyte Differentiation Antigen Workshop.
Journal: Clinical & translational immunology
Published: February 23, 2016
Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell Migration.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 12, 2016
Last Updated: 09/26/2026